Stem cell liquid plus light for vitiligo
Part of Skin clinical trials.
This trial tests a new treatment for non-segmental vitiligo that uses a special liquid made from stem cells, applied through tiny needle pricks or small injections, alongside standard light therapy. It may help restore pigment to white patches with fewer side effects than traditional treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have non-segmental vitiligo, which means patches on both sides of your body.
- Your skin type is medium to dark (types III to V on the Fitzpatrick scale).
- Your vitiligo patches have been stable for at least 6 months (no new patches or growth).
- The affected skin covers between 1% and 20% of your body.
- You are willing to follow the full treatment schedule and attend all check-ups.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special cell product (exosomes from umbilical cord stem cells) can safely help treat vitiligo. If you qualify, you might get this experimental treatment to see if it can restore skin color.
This trial compares two types of needle treatments (needling and microneedling) combined with light therapy to see which works better for people with vitiligo that has lasted more than a year.
This study tests whether adding a short course of steroid pills (taken by mouth in a pulse pattern) to a skin-grafting procedure helps prevent a pale ring from forming around the treated spots in people with stable vitiligo. The procedure takes healthy, pigment-making skin cells from one area and applies them to the white patches.
This trial tests a surgery that uses your own skin cells to treat stable vitiligo patches. It may help when creams or light therapy haven't worked.
This study tests a combination of narrowband UVB light therapy and steroid cream to see how it affects the immune system in people with vitiligo. It may help reduce the white patches by calming the immune response.
This study tests a new medicine called LY4005130 for non-segmental vitiligo, a skin condition where patches lose pigment (color). The trial aims to see if this drug can help restore skin color and stop the spread of white patches.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.